patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: patientman../you misunderstood..I didn't indicate that you were a basher.

as for risks, lol..all penny stocks are risky, but the ones with patents have the best potential..Frank Carlucci evidently agrees with me..he owns 4.1% of this company and I do not think he agrees with you

if in doubt? don't! do your own DD ..I did mine, I have a ton of PLRS and plan on accumulating more

Share
New Message
Please login to post a reply